These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1478681)

  • 1. Hodgkin's disease cell lines: a model for interleukin-1-independent accessory cell function.
    McKenzie JL; Egner W; Calder VL; Hart DN
    Immunology; 1992 Nov; 77(3):345-53. PubMed ID: 1478681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human dendritic cells stimulate allogeneic T cells in the absence of IL-1.
    McKenzie JL; Prickett TC; Hart DN
    Immunology; 1989 Jul; 67(3):290-7. PubMed ID: 2527194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoplastic cells obtained from Hodgkin's disease function as accessory cells for mitogen-induced human T cell proliferative responses.
    Fisher RI; Bates SE; Bostick-Bruton F; Tuteja N; Diehl V
    J Immunol; 1984 May; 132(5):2672-7. PubMed ID: 6609204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoplastic cells obtained from Hodgkin's disease are potent stimulators of human primary mixed lymphocyte cultures.
    Fisher RI; Bostick-Bruton F; Sauder DN; Scala G; Diehl V
    J Immunol; 1983 Jun; 130(6):2666-70. PubMed ID: 6222113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and characterization of a monoclonal antibody that binds Reed-Sternberg cells.
    Hecht TT; Longo DL; Cossman J; Bolen JB; Hsu SM; Israel M; Fisher RI
    J Immunol; 1985 Jun; 134(6):4231-6. PubMed ID: 3157756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potent mixed leukocyte reaction-stimulatory cells in human bone marrow. Putative differentiation stage of human blood dendritic cells.
    Egner W; McKenzie JL; Smith SM; Beard ME; Hart DN
    J Immunol; 1993 Apr; 150(7):3043-53. PubMed ID: 8454872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma irradiation of human dendritic cells influences proliferation and cytokine profile of T cells in autologous mixed lymphocyte reaction.
    Cao MD; Chen ZD; Xing Y
    Cell Biol Int; 2004; 28(3):223-8. PubMed ID: 14984749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodular sclerosing, mixed cellularity and lymphocyte-depleted variants of Hodgkin's disease are probable dendritic cell malignancies.
    Kennedy IC; Hart DN; Colls BM; Nimmo JC; Willis DA; Angus HB
    Clin Exp Immunol; 1989 Jun; 76(3):324-31. PubMed ID: 2787713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step.
    Morel AS; Quaratino S; Douek DC; Londei M
    Eur J Immunol; 1997 Jan; 27(1):26-34. PubMed ID: 9021994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7/BB-1 is a leucocyte differentiation antigen on human dendritic cells induced by activation.
    Hart DN; Starling GC; Calder VL; Fernando NS
    Immunology; 1993 Aug; 79(4):616-20. PubMed ID: 8406586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumor cells.
    Plumas J; Chaperot L; Jacob MC; Molens JP; Giroux C; Sotto JJ; Bensa JC
    Eur J Immunol; 1995 Dec; 25(12):3332-41. PubMed ID: 8566020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells.
    Gruss HJ; Brach MA; Drexler HG; Bonifer R; Mertelsmann RH; Herrmann F
    Cancer Res; 1992 Jun; 52(12):3353-60. PubMed ID: 1596893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tumour necrosis factor-alpha in dendritic cell-mediated primary mixed leucocyte reactions.
    McKenzie JL; Calder VL; Starling GC; Hart DN
    Bone Marrow Transplant; 1995 Feb; 15(2):163-71. PubMed ID: 7773205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional differences and complementation between dendritic cells and macrophages in T-cell activation.
    Guidos C; Sinha AA; Lee KC
    Immunology; 1987 Jul; 61(3):269-76. PubMed ID: 2956179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-leucocyte common (CD45) antibodies inhibit dendritic cell stimulation of CD4 and CD8 T-lymphocyte proliferation.
    Prickett TC; Hart DN
    Immunology; 1990 Feb; 69(2):250-6. PubMed ID: 1968425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathways of adhesion in spontaneous rosetting of T-lymphocytes to the Hodgkin's cell line L428.
    Sanders ME; Makgoba MW; Sussman EH; Luce GE; Cossman J; Shaw S
    Cancer Res; 1988 Jan; 48(1):37-40. PubMed ID: 3275493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen presentation by Hodgkin's disease cells.
    Fisher RI; Cossman J; Diehl V; Volkman DJ
    J Immunol; 1985 Nov; 135(5):3568-71. PubMed ID: 3876389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroviral interleukin-7 gene transfer into human dendritic cells enhances T cell activation.
    Westermann J; Aicher A; Qin Z; Cayeux Z; Daemen K; Blankenstein T; Dörken B; Pezzutto A
    Gene Ther; 1998 Feb; 5(2):264-71. PubMed ID: 9578847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of antigen-independent and antigen-dependent interaction of dendritic cells with CD4+ T cells.
    Hauss P; Selz F; Cavazzana-Calvo M; Fischer A
    Eur J Immunol; 1995 Aug; 25(8):2285-94. PubMed ID: 7545116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.